Literature DB >> 22907626

Growth hormone deficiency and cardiovascular risk: do we need additional markers?

M Gola, A Giustina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22907626     DOI： 10.1007/s12020-012-9769-x

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  29 in total

1.  The effects of resistance training on ApoB/ApoA-I ratio, Lp(a) and inflammatory markers in patients with type 2 diabetes.

Authors:  Nikolaos P E Kadoglou; Grigorios Fotiadis; Zoi Athanasiadou; Ioulia Vitta; Stylianos Lampropoulos; Ioannis S Vrabas
Journal:  Endocrine       Date:  2012-03-11       Impact factor: 3.633

2.  Increase in serum pregnancy-associated plasma protein-A is correlated with increase in cardiovascular risk factors in adult patients with growth hormone deficiency.

Authors:  Linman Li; Wei Ren; Jinchao Li; Jingjing Liu; Lingli Wang; Xiaoya Zheng; Dezhen Liu; Sufang Li; Rhonda Souvenir; Jiping Tang
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

3.  C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992.

Authors:  W Koenig; M Sund; M Fröhlich; H G Fischer; H Löwel; A Döring; W L Hutchinson; M B Pepys
Journal:  Circulation       Date:  1999-01-19       Impact factor: 29.690

4.  The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study.

Authors:  Annamaria Colao; Carolina di Somma; Rosario Pivonello; Alberto Cuocolo; Letizia Spinelli; Domenico Bonaduce; Marco Salvatore; Gaetano Lombardi
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

5.  The relationship between high-sensitivity C-reactive protein and ApoB, ApoB/ApoA1 ratio in general population of China.

Authors:  Wanhua Xu; Rong Li; Suhua Zhang; Lilin Gong; Zhihong Wang; Wei Ren; Chenxi Xia; Qifu Li
Journal:  Endocrine       Date:  2012-01-15       Impact factor: 3.633

6.  Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis.

Authors:  Christopher Heeschen; Stefanie Dimmeler; Christian W Hamm; Stephan Fichtlscherer; Maarten L Simoons; Andreas M Zeiher
Journal:  J Am Coll Cardiol       Date:  2005-01-18       Impact factor: 24.094

7.  Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial.

Authors:  G Sesmilo; B M Biller; J Llevadot; D Hayden; G Hanson; N Rifai; A Klibanski
Journal:  Ann Intern Med       Date:  2000-07-18       Impact factor: 25.391

8.  Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency? Data from the Dutch National Registry of Growth Hormone Treatment in adults.

Authors:  Christa C van Bunderen; I Caroline van Nieuwpoort; Lucia I Arwert; Martijn W Heymans; Anton A M Franken; Hans P F Koppeschaar; Aart J van der Lely; Madeleine L Drent
Journal:  J Clin Endocrinol Metab       Date:  2011-08-17       Impact factor: 5.958

9.  Premature mortality due to cardiovascular disease in hypopituitarism.

Authors:  T Rosén; B A Bengtsson
Journal:  Lancet       Date:  1990-08-04       Impact factor: 79.321

10.  Cardiac effects of growth hormone in adults with growth hormone deficiency: a meta-analysis.

Authors:  Patrick Maison; Philippe Chanson
Journal:  Circulation       Date:  2003-11-17       Impact factor: 29.690
View more
  5 in total

Review 1.  The metabolic effects of growth hormone in adipose tissue.

Authors:  Valéria Ernestânia Chaves; Fernando Mesquita Júnior; Gisele Lopes Bertolini
Journal:  Endocrine       Date:  2013-02-21       Impact factor: 3.633

2.  Fabula (non) acta est….Endocrine.

Authors:  Andrea Giustina
Journal:  Endocrine       Date:  2018-12       Impact factor: 3.633

Review 3.  Unusual effects of GH deficiency in adults: a review about the effects of GH on skin, sleep, and coagulation.

Authors:  F Tanriverdi; Z Karaca; K Unluhizarci; F Kelestimur
Journal:  Endocrine       Date:  2014-05-11       Impact factor: 3.633

4.  Alteration of the growth hormone axis, visceral fat dysfunction, and early cardiometabolic risk in adults: the role of the visceral adiposity index.

Authors:  Carolina Di Somma; Alessandro Ciresi; Marco C Amato; Silvia Savastano; Maria Cristina Savanelli; Elisabetta Scarano; Annamaria Colao; Carla Giordano
Journal:  Endocrine       Date:  2014-11-09       Impact factor: 3.633

5.  The visceral adiposity index is associated with insulin sensitivity and IGF-I levels in adults with growth hormone deficiency.

Authors:  Alessandro Ciresi; Stefano Radellini; Valentina Guarnotta; Carla Giordano
Journal:  Endocrine       Date:  2016-08-13       Impact factor: 3.633
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.